Neuropharmacology

Emory University is a global leader in neurobiology and the treatment of neuropsychiatric disorders, epilepsy, and substance abuse. The program’s prestige is highlighted by its 13 faculty members who belong to the American College of Neuropsychopharmacology—more than any other university. Research at Emory is anchored by extensive expertise in neuropharmacology, specifically regarding anxiolytics, antidepressants, and antipsychotics. Key focus areas include the neurobiological substrates of social behavior, fear, and depression, as well as molecular studies of G-protein-coupled signal transduction and glutamate receptor functions in neurodegeneration.